BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 22321194)

  • 1. β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB₁ or CB₂ receptors.
    Benito C; Tolón RM; Castillo AI; Ruiz-Valdepeñas L; Martínez-Orgado JA; Fernández-Sánchez FJ; Vázquez C; Cravatt BF; Romero J
    Br J Pharmacol; 2012 Jun; 166(4):1474-89. PubMed ID: 22321194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase.
    Carey LM; Slivicki RA; Leishman E; Cornett B; Mackie K; Bradshaw H; Hohmann AG
    Mol Pain; 2016; 12():. PubMed ID: 27178246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.
    Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A
    Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey.
    Kawahara H; Drew GM; Christie MJ; Vaughan CW
    Br J Pharmacol; 2011 Jul; 163(6):1214-22. PubMed ID: 21175570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.
    Booker L; Kinsey SG; Abdullah RA; Blankman JL; Long JZ; Ezzili C; Boger DL; Cravatt BF; Lichtman AH
    Br J Pharmacol; 2012 Apr; 165(8):2485-96. PubMed ID: 21506952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis.
    Malek N; Mrugala M; Makuch W; Kolosowska N; Przewlocka B; Binkowski M; Czaja M; Morera E; Di Marzo V; Starowicz K
    Pain; 2015 May; 156(5):890-903. PubMed ID: 25719612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice.
    Bashashati M; Storr MA; Nikas SP; Wood JT; Godlewski G; Liu J; Ho W; Keenan CM; Zhang H; Alapafuja SO; Cravatt BF; Lutz B; Mackie K; Kunos G; Patel KD; Makriyannis A; Davison JS; Sharkey KA
    Br J Pharmacol; 2012 Mar; 165(5):1556-71. PubMed ID: 21883147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture.
    Aguirre-Rueda D; Guerra-Ojeda S; Aldasoro M; Iradi A; Obrador E; Mauricio MD; Vila JM; Marchio P; Valles SL
    PLoS One; 2015; 10(4):e0122843. PubMed ID: 25874692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
    Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K
    Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High fat diet induced obesity alters endocannabinoid and ghrelin mediated regulation of components of the endocannabinoid system in nodose ganglia.
    Christie S; O'Rielly R; Li H; Wittert GA; Page AJ
    Peptides; 2020 Sep; 131():170371. PubMed ID: 32659299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.
    Bosier B; Muccioli GG; Lambert DM
    Br J Pharmacol; 2013 Jun; 169(4):794-807. PubMed ID: 22970888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of endocannabinoid and endovanilloid systems on aversive memory extinction.
    Laricchiuta D; Centonze D; Petrosini L
    Behav Brain Res; 2013 Nov; 256():101-7. PubMed ID: 23948212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception.
    Naidu PS; Booker L; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2009 Apr; 329(1):48-56. PubMed ID: 19118134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia.
    Lichtman AH; Shelton CC; Advani T; Cravatt BF
    Pain; 2004 Jun; 109(3):319-327. PubMed ID: 15157693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
    Danandeh A; Vozella V; Lim J; Oveisi F; Ramirez GL; Mears D; Wynn G; Piomelli D
    Psychopharmacology (Berl); 2018 Nov; 235(11):3211-3221. PubMed ID: 30251159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
    Nozaki C; Markert A; Zimmer A
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1388-96. PubMed ID: 25910421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
    Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
    Neuropsychopharmacology; 2009 Feb; 34(3):593-606. PubMed ID: 18580871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.
    Maione S; De Petrocellis L; de Novellis V; Moriello AS; Petrosino S; Palazzo E; Rossi FS; Woodward DF; Di Marzo V
    Br J Pharmacol; 2007 Mar; 150(6):766-81. PubMed ID: 17279090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Understanding of the Activation of CB1 and Blockade of TRPV1 Receptors: Implications for Novel Treatment Strategies in Osteoarthritis.
    Mlost J; Kostrzewa M; Malek N; Starowicz K
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.